TheNigerian news portal is a citizen’s online publishing and broadcasting platform combined with patriotic zeal to usher in positive narratives about the image of our country and it’s citizens. The portal was inaugurated in the united kingdom in 2016 and has consistently demonstrated fair, unbiased and transparent reportage of evolving developmental issues across the globe and particularly feeding its international audience in the accurate, facts-filled and truthful reports in and around the globe. As to remain as giants of both online publishing and broadcasting. TheNigerian news has recently launched "Television Nigerian" currently streaming in social media platforms as a web-TV

Russia completes human trials of Covid-19 vaccine, launch set for August

 

Russia has become the first country to have completed clinical trials of a Covid-19 vaccine candidate, after Sechenov University said that it had concluded its study.

According to Sechenov University Center for Clinical Research on Medications head and chief researcher Elena Smolyarchuk, study data showed the vaccine candidate’s effectiveness, reported Russian news agency TASS.

Smolyarchuk was quoted by the news agency as saying: “The research has been completed and it proved that the vaccine is safe. The volunteers will be discharged on 15 July and 20 July.”

The trial participants will be monitored on an outpatient basis after being discharged.

Last month, Russia granted authorisation for clinical trials of two formulations of the Covid-19 vaccine candidate, which was developed by the Gamaleya National Research Center for Epidemiology and Microbiology.

An intramuscular solution of the vaccine was tested at the Burdenko Military Hospital while Sechenov University assessed the vaccine in the form a powder for the preparation of an intramuscular solution.

The first stage of testing at the university commenced on 18 June in a group of 18 participants. The second group of the study involved 20 volunteers who were vaccinated on 23 June.

The Gamalei center’s head Alexander Gintsburg told the state-run TASS news agency that he hopes the vaccine will “enter civil circulation” on Aug. 12-14. He added that he hopes private companies would begin mass production by September.

“The research has been completed and it proved that the vaccine is safe,” Yelena Smolyarchuk, the head of Sechenov University’s clinical research center, told TASS of its trial.

You might also like

Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept